Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BridgeBio Pharma, Inc. - Common Stock (NQ:BBIO)

76.18 -0.50 (-0.65%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about BridgeBio Pharma, Inc. - Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
BridgeBio Pharma Inc. (NASDAQ: BBIO) is a Stock Spotlight on 8/18
Via Investor Brand Network
News headline image
4 Analysts Have This to Say About BridgeBio Pharma ↗
 
Via Benzinga
News headline image
Wall Street Thinks BridgeBio Pharma Could Rise Over 40% -- But Will It? ↗
Its potential upcoming drug launch might not be enough. 
Via The Motley Fool
News headline image
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From BridgeBio Pharma, Inc.
Via GlobeNewswire
News headline image
BridgeBio Pharma Reports Second Quarter 2023 Financial Results and Business Update
From BridgeBio Pharma, Inc.
Via GlobeNewswire
News headline image
Expert Ratings for BridgeBio Pharma ↗
 
Via Benzinga
News headline image
7 A-Rated Stocks for Your August Buy List ↗
August is shaping up to be a great month for the stock market. Now you just need to make sure you own these A-rated stocks. 
Via InvestorPlace
News headline image
BridgeBio Pharma Announces Opportunity for Accelerated Approval Pathway in Limb-girdle Muscular Dystrophy Type 2I (LGMD2I/R9) Based on Glycosylated Alpha-dystroglycan (⍺DG) Levels and Announces First Patient Dosed in FORTIFY Phase 3 Study
From BridgeBio Pharma, Inc.
Via GlobeNewswire
News headline image
Could This Stock Be the Next Biotech Buyout? ↗
A buyout deal recently pushed Reata Pharmaceuticals stock 53% higher in a single trading session, leading investors to wonder who's next. 
Via The Motley Fool
News headline image
Why Shares of BridgeBio Pharma Skyrocketed This Week ↗
The biotech company saw strong results in a phase 3 trial. 
Via The Motley Fool
News headline image
Dow Jones Leads Market Advance As Tesla, Netflix, Taiwan Semiconductor Hit Growth: Weekly Review ↗
But all the major indexes are at or near 15-month highs. 
Via Investor's Business Daily
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 18, 2023 ↗
 
Via Benzinga
News headline image
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From BridgeBio Pharma, Inc.
Via GlobeNewswire
News headline image
Crude Oil Falls; GreenPower Motor Company Shares Spike Higher ↗
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining 0.25% on Monday. The Dow traded up 0.25% to 34,596.04 while the NASDAQ rose 0.92% to 14,243.64. The S&P 500, also rose,... 
Via Benzinga
News headline image
Playbook Revisited As UNH Beat Could Help Sagging Healthcare Stocks ↗
Last week saw a broadening of the rally as many top sectors were up over 3%. But healthcare was among the laggards up only 0.7%. 
Via Talk Markets
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers ProMIS Neurosciences, Inc. (NASDAQ: PMN) shares jumped 126.6% to $6.37. ProMIS showcased preclinical data at the Alzheimer's Association International Conference 2023 on computationally-derived... 
Via Benzinga
News headline image
BridgeBio (NASDAQ: BBIO) Announces Exceptionally Positive Outcomes in Phase 3 Study of Acoramidis
BridgeBio Pharma (NASDAQ: BBIO), a leading biopharmaceutical company, announced significant outcomes from the ATTRibute-CM, their Phase 3 study of acoramidis, 
Via Spotlight Growth
News headline image
Nasdaq Gains 100 Points; Guaranty Bancshares Posts Upbeat Results ↗
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Monday. The Dow traded up 0.19% to 34,574.01 while the NASDAQ rose 0.71% to 14,214.50. The S&P... 
Via Benzinga
News headline image
Why Are Telecom Stocks Down Today? ↗
Telecom stocks aren't doing so how on Monday after several players in the space were hit by downgrades and lowered price targets from Citi. 
Via InvestorPlace
News headline image
BridgeBio Launches 64% Higher, Pulling Alnylam And Ionis With It, On A 'Best-Case' In Heart Disease ↗
The companies are working on treatments for a leading cause of heart failure. 
Via Investor's Business Daily
BridgeBio Pharma Inc. (NASDAQ: BBIO) Records 52-Week High Monday Morning
Via Investor Brand Network
News headline image
Why Is BridgeBio (BBIO) Stock Up 63% Today? ↗
BridgeBio Pharma (BBIO) stock is climbing higher on Monday as investors react to results from a recent Phase 3 clinical trial. 
Via InvestorPlace
News headline image
US Stocks Edge Higher; NY Empire State Manufacturing Index Falls In July ↗
U.S. stocks traded slightly higher this morning, with the Dow Jones moving higher by around 20 points on Monday. Following the market opening Monday, the Dow traded up 0.06% to 34,529.57 while the... 
Via Benzinga
News headline image
You Can't Afford to Miss Monday's 2 Nasdaq Biotech Stock Movers ↗
Big gains are afoot even as the markets prepare for a flat open. 
Via The Motley Fool
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why BYND Cannasoft Enterprises Shares Are Trading Lower By 40%; Here Are 20 Stocks Moving Premarket ↗
Gainers 
Via Benzinga
News headline image
BridgeBio Pharma Shares Are Shooting Higher Today - Here's Why ↗
BridgeBio Pharma Inc (NASDAQ: BBIO) released results from ATTRibute-CM Phase 3 study of acoramidis in transthyretin  
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗
It's time to start off the trading week with a breakdown of all the biggest pre-market stock movers worth watching on Monday! 
Via InvestorPlace
News headline image
Activision Blizzard, Argenx And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
U.S. stock futures traded mixed this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.